Pimavanserin: A 2019 Clarification on the FDA Update
Prim Care Companion CNS Disord
.
2019 Dec 26;21(6):19l02495.
doi: 10.4088/PCC.19l02495.
Authors
Zeeshan Mansuri
1
2
,
Krupa Patel
3
,
Rupak Desai
4
,
Muhammad Khalid Zafar
2
,
Shailesh Jain
2
Affiliations
1
[email protected]
.
2
Department of Psychiatry, Texas Tech University Health Science Center at Odessa/Permian Basin, Odessa, Texas, USA.
3
Avalon University School of Medicine, Willemstad, Curaçao, The Netherlands Antilles.
4
Division of Cardiology, Atlanta Veterans Affairs Medical Center, Decatur, Georgia, USA.
PMID:
31877245
DOI:
10.4088/PCC.19l02495
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Parkinson Disease*
Piperidines
Psychotic Disorders*
Urea / analogs & derivatives
Substances
Piperidines
Urea
pimavanserin